News

Biograil has signed a Collaboration and License Agreement with Eli Lilly
Read more
Biograil closing of a Seed 2 funding of 3.2 million Euro.
Read more
Biograil has signed a Feasibility, Option and License Agreement with Janssen Biotech, Inc.
Read more
Biograil closing of a seed funding of 3 Million Euro
Read more
CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST
Read more